Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.600
-0.030 (-1.14%)
Sep 5, 2025, 4:10 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 505.61 million as of September 5, 2025. Its market cap has decreased by -10.26% in one year.
Market Cap
505.61M
Enterprise Value
774.50M
Revenue
741.27M
Ranking
n/a
PE Ratio
15.25
Stock Price
2.60
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 505.61M, a decrease of -26.75%. That is a compound annual growth rate of -6.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 505.61M | -26.13% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | 690.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 102.26B |
| Pro Medicus | 30.97B |
| Cochlear | 19.54B |
| Sonic Healthcare | 11.37B |
| Ramsay Health Care | 7.84B |
| Ansell | 4.99B |
| Telix Pharmaceuticals | 4.66B |
| Mesoblast | 2.55B |